I'm still a bit nervous about the MP acquisition, but so far that seems to be going ok. Am happy to wait for the full year results and see how we go with scale and diversification.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025